Application of CBD as drug for treating METH addiction
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- KUNMING MEDICAL UNIVERSITY
- Publication Date
- 2019-10-18
Smart Images

Figure 1 
Figure 2 
Figure 3
Abstract
Description
technical field
[0001] The invention relates to the field of medicine, in particular to the use of CBD as a medicine for treating METH addiction, and the effect of CBD as a Sigma1R / AKT / GSK-3β / CREB signaling pathway inhibitor in reducing methamphetamine-induced CPP in rats. Background technique
[0002] Methamphetamine (METH) belongs to amphetamine stimulants, is a highly dependent psychoactive substance, is the most popular new synthetic drug in today's society, the appearance is white transparent irregular crystals, commonly known as "ice", its It has the characteristics of strong mental dependence, high relapse rate and high neurotoxicity. Long-term use can have significant toxic effects on the nervous system and cause serious physical and psychological damage to the abuser. Numerous studies have shown that the dopamine system, activation of microglia, neuronal apoptosis, and autophagy are involved in METH-induced neurotoxicity. But so far, the mechanism of METH-induced ...